These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 3476291)

  • 1. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.
    Quentin C; Saivin S; Lafferriere C; Noury P; Bebear C
    Drugs Exp Clin Res; 1987; 13(4):219-24. PubMed ID: 3476291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro action of fosfomycin combined with rifampicin, pefloxacin and imipenem on staphylococci (checkerboard method in a liquid medium)].
    Quentin C; Noury P; Laurent C; Saivin S; Bebear C
    Pathol Biol (Paris); 1987 Feb; 35(2):153-7. PubMed ID: 3550623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
    Ishag AJ; Durgham SM; Shibl AM
    Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro study of the effects of an imipenem-fosfomycin combination against clinical strains of Staphylococcus].
    Fosse T; David MF; Duluc F
    Pathol Biol (Paris); 1986 Dec; 34(10):1055-9. PubMed ID: 3547260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci].
    Fosse T; David MF; Duluc F; Darmusey D; Tamalet C; Toga B
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):528-31. PubMed ID: 6462742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synergy, addition, indifference, antagonism and dominance. Dominance and antibiotic combination].
    Drugeon HB; Dellamonica P; Caillon J
    Pathol Biol (Paris); 1987 May; 35(5):495-500. PubMed ID: 3302851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of imipenem against enterococci and staphylococci and evidence for high rates of synergism with teicoplanin, fosfomycin, and rifampin.
    Debbia E; Varaldo PE; Schito GC
    Antimicrob Agents Chemother; 1986 Nov; 30(5):813-5. PubMed ID: 2948444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.
    Sahuquillo Arce JM; Colombo Gainza E; Gil Brusola A; Ortiz Estévez R; Cantón E; Gobernado M
    Rev Esp Quimioter; 2006 Sep; 19(3):252-7. PubMed ID: 17099793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus].
    Zuccarelli M; Simeon de Buochberg M; Maillols M; Armynot du Chatelet AM; Attisso MA
    Pathol Biol (Paris); 1988 May; 36(5):403-9. PubMed ID: 3136422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy of fosfomycin with beta-lactam antibiotics against staphylococci and aerobic gram-negative bacilli.
    Chin NX; Neu NM; Neu HC
    Drugs Exp Clin Res; 1986; 12(12):943-7. PubMed ID: 3569007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of coumermycin alone or in combination against Staphylococcus aureus and Staphylococcus epidermidis.
    Van der Auwera P; Klastersky J
    Drugs Exp Clin Res; 1986; 12(4):307-11. PubMed ID: 3013562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro effect of combinations of netilmicin and amikacin with fosfomycin and pefloxacin on 31 strains of heterogeneous methicillin- resistant Staphylococcus aureus].
    David C; Chaste A; Saison C; Combremont AG
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):608-12. PubMed ID: 3054735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killing rate and serum bactericidal activity of oxacillin, rifampin and ciprofloxacin against Staphylococcus aureus.
    Moretti MV; Fiorio M; Pasticci MB; Moretti A; Baldelli F; Pauluzzi S
    Microbiologica; 1989 Oct; 12(4):297-306. PubMed ID: 2586332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antistaphylococcal activity of pefloxacin alone and in combination with other antistaphylococcal drugs.
    Fass RJ; Helsel VL
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1457-60. PubMed ID: 3481244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro interactions between teicoplanin and other antibiotics against enterococci and staphylococci.
    Debbia E; Pesce A; Schito GC
    J Hosp Infect; 1986 Mar; 7 Suppl A():73-7. PubMed ID: 2871100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antibacterial activity of imipenem against Pseudomonas and Staphylococcus species. Comparison with thirteen other antimicrobial agents.
    Cristiano P; Abbate GF; Alagia I; Leonessa V; Giaquinto E; Savioli L
    Drugs Exp Clin Res; 1985; 11(1):39-48. PubMed ID: 3869802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin.
    Graninger W; Leitha T; Breyer S; Francesconi M; Lenz K; Georgopoulos A
    Drugs Exp Clin Res; 1985; 11(1):23-7. PubMed ID: 3869801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
    Pruekprasert P; Tunyapanit W
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters.
    Simon VC; Simon M
    Scand J Infect Dis Suppl; 1990; 72():14-9. PubMed ID: 2151061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of pefloxacin against gram-negative and gram-positive bacteria in comparison with other antibiotics.
    Debbia E; Schito GC; Nicoletti G; Speciale A
    Chemioterapia; 1987 Oct; 6(5):319-23. PubMed ID: 3480779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.